Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1997-07-01
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530303, 4241841, A61K 3820, A61K 3900, C07K 1462
Patent
active
056438680
ABSTRACT:
Disclosed herein are methods for treating or preventing a disease in mammals having the characteristics of Type 1 diabetes comprising administering insulin or disease suppressive fragments of insulin or analogs thereof in oral or aerosol dosage forms to said mammals. Also disclosed herein are pharmaceutical formulation or dosage forms for use in the methods.
REFERENCES:
patent: 3561444 (1971-02-01), Boucher
patent: 3594476 (1971-07-01), Merrill
patent: 3703173 (1972-11-01), Dixon et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4362719 (1982-12-01), Cavazza
patent: 4529589 (1985-07-01), Davydov et al.
patent: 4556552 (1985-12-01), Porter et al.
patent: 4579730 (1986-04-01), Kidron
patent: 4598065 (1986-07-01), Lundt et al.
patent: 4608364 (1986-08-01), Grau
patent: 4624251 (1986-11-01), Miller
patent: 4635627 (1987-01-01), Gam
patent: 4659696 (1987-04-01), Hirai et al.
patent: 4704295 (1987-11-01), Porter et al.
patent: 4789660 (1988-12-01), Enever et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4963526 (1990-10-01), Ecanow
Foster, D.W., Harrison's Principles of Internal Medicine, Ch. 114, pp. 661-678, 10th Ed., McGraw-Hill, New York.
Foster, D.W., Harrison's Principles of Internal Medicine, Ch. 114, p. 668, 10th Ed., McGraw-Hill, New York.
Nakhooda, A.F., et al., Diabetologia, 14:199-207 (1978).
Dayhoff, M.O., Atlas of Protein Sequence and Structure, 5:209-11 (1972).
Gorman, C., Time Magazine, Jun. 10, 1991, p. 54.
Dunlop, M., Toronto Star, May 4, 1991, p. G2.
Rennie, J., Scientific American, 263(6):106 (Dec. 1990).
Associated Press (Washington), May 25, 1990.
Recer, P., Associated Press (Washington), May 24, 1990.
Cooke, R., Newsday, Dec. 12, 1989, p. 1.
Maugh, T.H., Los Angeles Times, Oct. 12, 1989, p. A3, col. 1.
Biotechnology Newswatch, 9(9):5 (May 1, 1989).
Knox, R.A. The Boston Globe, Feb. 9, 1990, p. 5.
Braley-Mullen, H. et al., 1980, Cell. Immunol., 51: 408-413.
Keller, R.J., 1990, J. Autoimmun., 3:321-327.
Harrison, L. et al., 1992, J. Clin. Invest.: 1161-65.
Dean et al. Diabetologia (1986) vol 29 339-342.
Zhang et al. PNAS (Nov. 1991) pp. 1-16.
Eisenbarth, G.S., New Engl. J. Med. 314:1360-1368, 1986.
Prochazka et al., Science 237:286, 1987.
Bendelac, A. et al., J. Exp. Med. 166:823, 1987.
Nagler-Anderson, et al., Proc. Natl. Acad. Sci. (USA) 83:7443-7446, 1986.
Merrifield, R.B., Fed. Proc. Am. Soc. Ex. Biol. 21:412, 1962.
Mitchell, A.R. et al., J. Am. Chem. Soc. 98:7357, 1976.
Tam, J. et al., J. Am. Chem. Soc. 105:6442, 1983.
Newman, S.P., Aerosols and the Lung, Clarke, S.W. and Davis, D. eds. pp. 197-224, Butterworths, London.
Eisenbarth George
Hafler David Allen
Weiner Howard L.
Zhang Zhengyi
AutoImmune Inc.
Hutzell Paula K.
Prickril Benet
LandOfFree
Method of treating or preventing type 1 diabetes by oral adminis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating or preventing type 1 diabetes by oral adminis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating or preventing type 1 diabetes by oral adminis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597003